RETRACTED: Experimental use of the antiviral drug "Triazavirin" for the treatment of calves with symptoms of respiratory system damage
See the retraction notice E3S Web of Conferences 420, 00001 (2023), https://doi.org/10.1051/e3sconf/202342000001
Saved in:
Main Authors: | Reshetnikova Tatiana, Kuzmin Vladimir, Krylova Tatyana |
---|---|
Format: | Article |
Language: | English |
Published: |
EDP Sciences
2023-01-01
|
Series: | E3S Web of Conferences |
Online Access: | https://www.e3s-conferences.org/articles/e3sconf/pdf/2023/57/e3sconf_ebwff2023_05010.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advances and Challenges in Antiviral Development for Respiratory Viruses
by: Luis Adrián De Jesús-González, et al.
Published: (2024-12-01) -
Respiratory Support for Pharmacologically Induced Hypoxia in Neonatal Calves
by: C. G. Donnelly, et al.
Published: (2016-01-01) -
Virus isolation from calves with respiratory tract disease
by: Feridun Öztürk, et al. -
Detection and molecular characterization of mastadenoviruses in calves with respiratory system infection
by: İlke Karayel Hacıoğlu, et al.
Published: (2022-06-01) -
Antiviral Drugs Used to Treat COVID-19 are not Liver Safe: A Comparative Experimental Study
by: Asiye Aslı Emniyet Sert, et al.
Published: (2024-07-01)